Nexalin Technology, Inc. (NXL) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Nexalin Technology, Inc. in 2026. The next earnings report is expected on September 2, 2026.
Next earnings date
02 Sep 2026
In 14 days
EPS estimate
-0.10
Revenue estimate
90.0K
Past earnings
No dividend history available.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
Nexalin Technology, Inc. (NXL) is scheduled to report earnings on September 2, 2026.
Nexalin Technology, Inc. (NXL) last reported earnings on August 12, 2026.
Nexalin Technology, Inc. (NXL) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.